High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma

Kai Yuan; Zhao-Jia Gao; Wei-Dong Yuan; Jun-Qiang Yuan; Yong Wang

High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma

Int J Clin Exp Pathol. 2018 Feb 1;11(2):720-726. eCollection 2018.

Authors

Kai Yuan^{1

2}, Zhao-Jia Gao^{1

2}, Wei-Dong Yuan¹, Jun-Qiang Yuan¹, Yong Wang¹

Affiliations

¹ Division of Thoracic Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University Changzhou, Jiangsu Province, China.
² Heart and Lung Disease Laboratory, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University Changzhou, Jiangsu Province, China.

PMID: 31938158
PMCID: PMC6958030

Abstract

Purpose: To investigate the expression profile and prognostic value of SLC6A10P in patients with non-small cell lung cancer (NSCLC).

Patients and methods: TCGA datasets were used to investigate the differential expression of SLC6A10P in NSCLC, lung adenocarcinoma (LUAD), and lung squamous cell carcinoma (LUSC). Expression of SLC6A10P was measured by in situ hybridization in tissue microarrays containing 136 NSCLC (51 LUAD and 85 LUSC) patients. The prognostic value of SLC6A10P was then evaluated.

Results: SLC6A10P was highly expressed in tumor tissues compared with normal lung tissues. High SLC6A10P expression was associated with lymph node metastasis (NSCLC, P = 0.0054; LUAD, P = 0.0149), more advanced tumor stage (NSCLC, P = 0.0126; LUAD, P = 0.0416) and poor overall survival (NSCLC, P = 0.0248; LUAD, P = 0.0316) in NSCLC and LUAD. Multivariate analysis revealed that SLC6A10P was an independent prognostic factor in LUAD patients (P = 0.017). SLC6A10P showed no association with clinicopathological parameters and no prognostic value in LUSC.

Conclusion: SLC6A10P is highly expressed in tumor tissues and its high expression predictspoor survival in patients with LUAD. SLC6A10P might serve as a novel therapeutic target and prognostic biomarker in LUAD patients in the future.

Keywords: SLC6A10P; bioinformatics; lung adenocarcinoma; prognosis; pseudogene.